drugset / Trial / NCT05842733
A Novel, Potent and Non-addictive Analgesic of Combinations for Knee Replacement Moderate to Severe Pain Management
RandomizedParallel-groupDouble-blindTreatment
Summary
To assess the safety, efficacy, and pharmacokinetics of oral SafeTynadol, Naldebain and Naldebain combine with SafeTynadol in the treatment of moderate to severe pain following knee replacement.
Timeline
- Start
- 2023-07-25
- Primary completion
- 2024-12-31
- Completion
- 2024-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Dinalbuphine sebacate | Small molecule | 37.5 mg | Oral |
| Comparator | SafeTynadol | Unknown | 650 mg | Oral |